| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Canada | 6 | |
| #2 | United States | 6 | |
| #3 | EPO (European Patent Office) | 5 | |
| #4 | Brazil | 4 | |
| #5 | Republic of Korea | 4 | |
| #6 | Norway | 3 | |
| #7 | South Africa | 3 | |
| #8 | China | 2 | |
| #9 | Japan | 2 | |
| #10 | Mexico | 2 | |
| #11 | WIPO (World Intellectual Property Organization) | 2 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Pharmaceuticals | |
| #3 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations | |
| #4 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Jennings Philip Anthony | 24 |
| #2 | Doyle Anthony Gerard | 23 |
| #3 | Clarke Adam William | 13 |
| #4 | Woolven Benjamin P | 11 |
| #5 | Tomlinson Ian M | 11 |
| #6 | Lee Jennifer A | 9 |
| #7 | Aston Roger | 7 |
| #8 | Gay Robert Daniel | 6 |
| #9 | Rathjen Deborah A | 5 |
| #10 | Gerard Doyle Anthony | 4 |
| Publication | Filing date | Title |
|---|---|---|
| US2008255343A1 | Chimeric antibodies | |
| WO2008092209A1 | Protein construct with improved properties | |
| BRPI0707425A2 | domain antibody construction, isolated nucleic acid molecule, pharmaceutical composition, and methods for detecting human tnf-alpha in a sample, and for treating a disorder | |
| CN101287763A | Chimeric antibodies with new world primate regions | |
| US2006182746A1 | Tumour necrosis factor binding ligands |